Document Detail


Clinical toxicity of furosemide in hospitalized patients. A report from the Boston Collaborative Drug Surveillance Program.
MedLine Citation:
PMID:  868744     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Of 17,068 hospitalized medical patients monitored in a drug surveillance program, 2,367 (13.9 per cent) received furosemide. Of these patients, 53 per cent were hospitalized with a primary (first) diagnosis of cardiovascular disease; many other patients had cardiovascular disorders coincident with other diseases. In 78 per cent of cases the indication for furosemide therapy was congestive heart failure. Adverse reactions were attributed to furosemide in 239 patients (10.1 per cent), but in only 14 instances were the unwanted effects considered life-threatening. The most common adverse reactions were: intravascular volume depletion (4.6 per cent of furosemide recipients), hypokalemia (3.6 per cent), and other eletrolyte disturbances (1.5 per cent). Many patients experienced more than one manifestation of toxicity. The over-all frequency of adverse reactions increased progressively with higher daily doses of furosemide, but was not correlated with total furosemide dose. Among furosemide recipients who also recieved potassium-supplements or potassium-sparing diuretics, hypokalemia was less frequent, less severe, and of slower onset. Coadministration of other diuretics with furosemide was associated with a higher frequency of volume depletion. The findings indicate that furosemide is a relatively safe diuretic in a wide range of clinical situations. Serious adverse reactions are uncommon, and occur primarily in the seriously ill.
Authors:
D J Greenblatt; D W Duhme; M D Allen; J Koch-Weser
Related Documents :
2256494 - Neuroophthalmologic effects of intravenous magnesium sulfate.
2729314 - Dosing of contrast material to prevent contrast nephropathy in patients with renal dise...
596244 - Studies on digitalis. xiv. is there any correlation between hypomagnesemia and digitali...
22568544 - Pectus excavatum and mass phenotype: an unknown association.
19547834 - Angioarchitecture and clinical presentation of brain arteriovenous malformations.
19908144 - Adsorptive depletion of alpha4 integrin(hi)- and cx3cr1hi-expressing proinflammatory mo...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  94     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1977 Jul 
Date Detail:
Created Date:  1977-07-29     Completed Date:  1977-07-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  6-13     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Canada
Drug Information Services
Drug Therapy, Combination
Female
Furosemide / adverse effects*
Hospitalization
Humans
Israel
Male
Middle Aged
New Zealand
United States
Chemical
Reg. No./Substance:
54-31-9/Furosemide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of test site on ventricular fibrillation threshold.
Next Document:  The thoracic windows for electrical ventricular defibrillation current.